Phase 2 Study of Nivolumab in Patients with Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
The goal of this clinical research study is to learn if nivolumab can help to control MF. The safety of this drug will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 05/14/2015
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: